- Disease
- Thursday, 20 Feb 2020
Stock Futures slips as coronavirus cases outside China rise
U.S. stock index futures fell on Thursday, a day after the S&P 500 and Nasdaq closed at record levels, as the number of coronavirus cases outside China increased.
South Korea reported a spike in new cases on Thursday and Japan reported two new deaths while research suggested the virus spreads faster than previously thought.
Iranian health officials urged all religious gatherings to be suspended in Qom, news agency ISNA said, after two more people tested positive for the coronavirus in the holy city, where two died of it this week.
China reported a sharp drop in new cases, but the data was treated with skepticism as another change in the diagnostic method raised questions about the extent to which daily tallies accurately reflect the state of the outbreak.
China lowered its benchmark lending rates, as expected, to cushion the blow to growth from the epidemic that has disrupted global supply chains and upended business operations and factory activity.
Recent policy easing in the country, a largely better-than-expected fourth quarter earnings season and hopes that the economic jolt from the outbreak will be short-lived have pushed Wall Street’s main indexes to new peaks in recent weeks.
At 7:09 a.m. ET, Dow e-minis 1YMcv1 were down 48 points, or 0.16%. S&P 500 e-minis EScv1 were down 5 points, or 0.15% and Nasdaq 100 e-minis NQcv1 were down 17.25 points, or 0.18%.
Related Industry Updates
Coronavirus on G20 agenda as China reports uptick in cases
Feb 21, 2020
Managing Your Orthopaedic Care during the COVID-19 Pandemic
May 06, 2020
Epinephrine Market New Innovative Solutions To Boost Global Growth With Top Key Players- Abbott, ALK ABELLO, Amneal Pharma, Kaleo, LINCOLN MEDICAL
Jun 04, 2020
Tumor Ablation Market 2021 Strong Revenue, Competitive Outlook by Top Competitors And Forecast To 2027
Apr 27, 2021
Top Human Capital Trends Fueling Workplace Innovation
May 20, 2020
South Africa's rand firmer as virus selloff pauses
Feb 03, 2020
Rare Neurological Disease Treatment Market Growth Insights to 2027 - Allergan, Bayer AG, GlaxoSmithKline, Johnson & Johnson Services
Apr 30, 2020